Potassium Chloride 0.15% + Glucose 5% B. Braun, 1.5 g/l + 55.0 g/l, solution for infusion
Potassium Chloride 0.3% + Glucose 5% B. Braun, 3.0 g/l + 55.0 g/l, solution for infusion
Potassium chloride and glucose
used
This medicine contains a solution of potassium chloride and glucose. It is administered through a thin tube directly into a vein (intravenous infusion).
The medicine will be administered to maintain or restore potassium levels and to meet energy needs.
Patients taking this medicine and who are also in a severe state, in pain, in a post-operative state, with infections, burns, nervous system disorders, heart, liver, or kidney disorders, as well as patients taking medicines that enhance the action of vasopressin (a hormone responsible for regulating the amount of fluids in the body), are particularly at risk of low sodium levels in the blood (acute hyponatremia), which can lead to brain swelling (encephalopathy).
Children, women of childbearing age, and patients with severe brain disorders, such as meningitis (infection of the membrane surrounding the brain) or patients with brain injuries, are particularly at risk of severe and life-threatening brain swelling caused by a sudden drop in sodium levels in the blood.
Before starting to take Potassium Chloride 0.15% 0.3% + Glucose 5%, you should discuss it with your doctor.
Before or during the administration of this medicine, the doctor will pay special attention to the following:
During the administration of this medicine, ECG results, fluid and electrolyte balance, and blood glucose levels will be regularly monitored.
Particular attention should be paid to the condition of elderly patients and the dose should be adjusted during the administration of this medicine to elderly patients, as they are more prone to heart and kidney disorders.
When using this medicine in children and adolescents, particular caution should be exercised.
Fluid and electrolyte balance should be closely monitored.
This medicine should be administered to children and adolescents with caution, especially in cases of low electrolyte levels, particularly sodium. The doctor will monitor electrolyte levels and fluid levels.
You should inform your doctor, nurse, or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take, especially:
You should inform your doctor if you are taking digoxin or similar medicines that support heart function, as Potassium Chloride 0.15% 0.3% + Glucose 5% B. Braun may affect their action. In such cases, it may be necessary to adjust the dose of Potassium Chloride 0.15% 0.3% + Glucose 5% B. Braun.
You should also inform your doctor if you are taking medicines that contain potassium or may increase potassium levels in the body:
as this may lead to heart problems (arrhythmias).When using certain medicines, such as corticosteroids, ACTH, and loop diuretics, potassium excretion by the kidneys may increase.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor before using this medicine.
This medicine may be administered to pregnant or breastfeeding women if the doctor decides so.
Potassium Chloride 0.15% 0.3% + Glucose 5% B. Braun does not affect the ability to drive or use machines.
This medicine should always be used in accordance with the doctor's recommendations. In case of doubts, you should consult your doctor.
Dosage
The recommended dose will be determined by the doctor based on the patient's age, weight, and condition, particularly heart and kidney function. During the administration of this medicine, blood glucose and electrolyte levels, fluid balance, and ECG results will be routinely monitored.
The doctor will ensure adequate urine output.
The recommended maximum dose for an adult patient is 40 ml/kg body weight/day. If it is necessary to use a larger amount of potassium, the doctor will consider using other strengths.
This medicine may be administered for as long as there are indications for the administration of energy, electrolytes, and fluids.
Elderly patients
Generally, the same dosage as for adult patients can be used. However, in the case of elderly patients, it may be necessary to adjust the dose to eliminate the risk of circulatory and kidney disorders.
Children and adolescents
In children and adolescents, the dose depends on individual needs. Smaller doses may be used.
Method of administration
This medicine will be administered through a tube inserted directly into a vein (intravenous infusion).
Taking too much of this medicine is unlikely, as the dose is determined by the doctor.
The doctor will monitor the patient's chemical balance and fluid balance, glucose and electrolyte levels (including sodium) in the blood before and during treatment, particularly in patients with vasopressin release disorders and patients taking medicines that enhance the action of vasopressin, due to the risk of low sodium levels in the blood (hyponatremia).
Overdose symptoms
In case of overdose, disturbances of electrolyte, sugar, water, and acid-base balance may occur. Fluid accumulation in the body and potassium poisoning may also occur.
In particular, potassium levels in the blood may rise significantly. Symptoms of this condition may include:
In case of any further doubts related to the use of this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Disturbances of fluid and electrolyte balance may occur. Low sodium, potassium, phosphate, and magnesium levels in the blood may occur. Low sodium levels in the blood may lead to a severe condition called hospital hyponatremia, which can cause irreversible brain damage and death due to brain swelling (hyponatremic encephalopathy). Symptoms of brain swelling include: headaches, nausea, vomiting, seizures, fatigue, and lack of energy.
Side effects should not be expected if this medicine is used according to the recommendations.
You should inform your doctor if you experience pain or excessive sensitivity to touch or if you notice red blood clots at the injection site.
If you experience any side effects, including any side effects not mentioned in the leaflet, you should inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Unopened packaging: do not store above 25°C.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the labels on the bottle and carton after EXP. The expiry date refers to the last day of the given month.
Do not use the medicine if it is cloudy or has changed color, if solid particles are visible in the solution, or if the packaging or closure is damaged.
The packaging is intended for single use only. The packaging and any remaining medicine should be discarded after use.
The medicine should be administered immediately. If the medicine is not administered immediately, the user is responsible for the storage period and conditions. Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Potassium Chloride 0.15% 0.3% + Glucose 5% B. Braun, solution for infusion, is a clear, colorless to slightly straw-colored solution of potassium chloride and glucose in water.
It is supplied in polyethylene bottles of 500 ml or 1000 ml, available in packs of 10.
and
Czech Republic
Potassium Chloride 0.15% 0.3% + Glucose 5% B. Braun
Estonia
Potassium Chloride/Glucose B. Braun 1.5 mg/ml (3 mg/ml) + 50 mg/ml, solution for infusion / infusion solution, solution / infusion liquid
Spain
Potassium Chloride 1.5 (3 mg/ml) mg/ml in Glucose 50 mg/ml Prediluido B. Braun solution for perfusion
Finland
Potassium Chloride/Glucose B. Braun 1.5 mg/ml (3 mg/ml) + 50 mg/ml, solution for infusion / infusion solution, solution / infusion liquid
Ireland
Potassium Chloride 0.15% (0.3%) w/v and Glucose 5% w/v solution for infusion
Netherlands
Potassium Chloride 0.15% 0.3% - Glucose 5%, solution for intravenous infusion
Poland
Potassium Chloride 0.15% 0.3% + Glucose 5% B. Braun
Portugal
Potassium Chloride 0.15% (0.3%) + Glucose 5% B.Braun
Slovakia
Potassium Chloride 0.15% 0.3% + Glucose 5% B. Braun
United Kingdom
Potassium Chloride 0.15% (0.3%) w/v and Glucose 5% w/v solution for infusion
Dosage
Adults:
The recommendations given below should be considered as general guidelines for potassium dosing, however, local guidelines should be followed.
Potassium
The amount of potassium required to correct moderate deficiencies and to maintain adequate potassium levels can be calculated using the following formula:
required amount of mmol K+ = (body weight [kg] x 0.2)* x 2 x (target K level in serum ** - actual K level in serum [mmol/l])
* Represents the extracellular fluid volume.
** Should be 4.5 mmol/l.
The maximum recommended dose of potassium is 2 to 3 mmol/kg body weight/day.
Maximum infusion rate:
Up to 5 ml/kg body weight per hour, which corresponds to 0.25 g glucose/kg body weight per hour.
Children and adolescents
Generally, the substitution rate should not exceed 0.5 mmol potassium/kg body weight per hour.
Maximum daily dose
The maximum recommended dose of potassium is 2 to 3 mmol/kg body weight per day. In no case should the daily fluid intake limit be exceeded.
Method of administration
As a rule, infusion pumps should be used for potassium infusion as part of replacement therapy.
Special warnings
Solutions with low electrolyte content, particularly sodium, should be administered with caution to patients with hyponatremia.
Cautious attention should be paid to avoiding a sudden drop in sodium levels in the blood, as this may be associated with the risk of osmotic damage to the central nervous system.
Children and adolescents
Infusion of hypotonic solutions with non-osmotic ADH release (in pain, post-operative phase, during nausea, vomiting) may lead to hyponatremia.
Treatment in case of overdose
Immediate discontinuation of the infusion, ECG monitoring, and if necessary, correction of urine output, and consequently fluid and electrolyte excretion, administration of sodium bicarbonate and insulin.
When administering insulin to increase cellular potassium uptake, glucose should be administered to avoid hypoglycemia. In case of persistent ECG abnormalities, calcium gluconate may be administered to counteract the cardiotoxic effect of potassium. Hemodialysis or peritoneal dialysis may be necessary in patients with renal failure.
Incompatibilities
Due to the lack of compatibility studies, this medicinal product should not be mixed with other medicinal products.
Shelf life after first opening of the packaging
From a microbiological point of view, mixtures should be administered immediately after preparation.
If the mixture is not administered immediately, the user is responsible for the storage period and conditions.
More information about this medicine can be found in the Summary of Product Characteristics.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.